Download
1 / 8
80 likes | 81 Views
According to our new research study, titled "Hydrocephalus Shunts Market Forecast to 2028 u2013 COVID-19 Impact and Global Analysis u2013 by Product, Type, Age Group, and End User," the hydrocephalus shunts market was valued US$ 286.19 million in 2021; it is estimated to grow at a CAGR of 3.4% from 2022 to 2028. The market growth is primarily attributed to the increasing prevalence of hydrocephalus and advancements in hydrocephalus valves.<br><br>for more..<br>https://www.theinsightpartners.com/reports/hydrocephalus-shunts-market
E N D
Hydrocephalus Shunts Market Global Analysis and Forecast to 2028 Published Date : Sep 2022 Email: sales@theinsightpartners.com
Email:sales@theinsightpartners.com Report Studies • Hydrocephalus Shunts Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Age Group (Pediatric and Adults), Type (Ventriculo-Peritoneal, Ventriculo-Atrial, Ventriculo-Pleural, and Lumbo-Peritoneal), Product (Hydrocephalus Valves, Hydrocephalus Catheters, Neuronavigation Systems, and Others), and End User (Hospitals, Ambulatory Surgical Centers, and Others)
Email:sales@theinsightpartners.com Hydrocephalus Shunts Market Value CAGR of 3.4% (2022 - 2028)
Email:sales@theinsightpartners.com Hydrocephalus Shunts Market Overview • According to our new research study, titled "Hydrocephalus Shunts Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Type, Age Group, and End User," the hydrocephalus shunts market was valued US$ 286.19 million in 2021; it is estimated to grow at a CAGR of 3.4% from 2022 to 2028. The market growth is primarily attributed to the increasing prevalence of hydrocephalus and advancements in hydrocephalus valves. However, the high cost of treatment involving shunts and the need for revision surgeries are hindering the growth of the market. • Based on type, the hydrocephalus shunts market is segmented into ventriculo-peritoneal, ventriculo-atrial, ventriculo-pleural, and lumbo-peritoneal. The ventriculo-peritoneal segment held the largest share of the market in 2021, and it is further anticipated to register the highest CAGR during the forecast period. According to the research paper published in the National Center for Biotechnology Information (NCBI), a ventriculo-peritoneal shunt is a highly impacted in neurosurgical patient care. This shunt can be lifesaving for benign disorders, and it is known for a good outcome among many patients.
Email:sales@theinsightpartners.com Key Segment Market Segment By Type:- • By Age Group (Pediatric and Adults) • By Type (Ventriculo-Peritoneal, Ventriculo-Atrial, Ventriculo-Pleural, and Lumbo-Peritoneal) • By Product (Hydrocephalus Valves, Hydrocephalus Catheters, Neuronavigation Systems, and Others) • By End User (Hospitals, Ambulatory Surgical Centers, and Others)
Email:sales@theinsightpartners.com Company Profiles • B. Braun Melsungen AG (CHRISTOPH MIETHKE GMBH & CO. KG) • Sophysa • HpBioPróteses, inc. • Integra LifeSciences Holdings Corporation • KANEKA MEDIX CORP. • Medtronic • Natus Medical Incorporated • Spiegelberg GmbH & Co. KG • Desu Medical Download Sample Here
Email:sales@theinsightpartners.com By Geography • North America (the US, Canada, and Mexico) • Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe) • Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific) • Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa) • South & Central America (Brazil, Argentina, and the Rest of South & Central America).
THANKYOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com
